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Abstract
Due to the COVID-19 pandemic, most memory clinics have had to suspend their activities. On the other hand, international
dementia experts have recommended to provide urgently worldwide support for people living with dementia. This situation urges
to play out new strategies to guarantee adequate care. Telemedicine and digital technology (DT) devices, such as smartphones,
can be very helpful in remote monitoring and care. Technological devices such as videoconference or smartphone apps might be
used for follow-up visits and support to patients and caregivers and to acquire digital markers of clinical progression. Hopefully,
this dramatic situation would facilitate the process of progressive familiarization of neurologists with telemedicine and DT
approach.
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The severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) rapidly caused a pandemic of coronavirus disease
2019 (COVID-19), greatly stressing the healthcare systems
worldwide. The social restrictions have had a substantial im-
pact on the management of outpatient clinics with cancel-
ations or postponement of outpatient visits [1]. Vulnerable
patients, as elderly people with cognitive impairment (CI)
or dementia, have an increased risk of serious morbidity,
admission to intensive care units, and death when infected
with COVID-19 because of their advanced age and frequent
medical comorbidities. Consequently, they have been highly
recommended to adhere to social distancing, increasing care-
giver burden. Furthermore, these measures might lead pa-
tients with CI to a faster cognitive deterioration and to wors-
ening of behavioral and psychological symptoms of demen-
tia, inducing in turn higher caregiver distress. National and
International Societies have made several recommendations
about dementia care addressed to all dementia patients and
their caregivers [2].
Unlike other neurological disorders, people with CI do not
usually require frequent visits; however, as the general popu-
lation age increases, memory clinics tend to be increasingly
overcrowded due to diagnostic processes of early stage CI
patients (requiring closer monitoring of symptoms progres-
sion) and long-term management of chronic patients.
As future COVID-19 outbreaks cannot be excluded to oc-
cur in the upcoming months, neurologists are forced to adopt
new strategies to guarantee minimal standards of care for their
patients and limit hospital access of elderly people to protect
them from infection.
COVID-19 pandemic is accelerating telemedicine and
digital technology (DT) use for chronic neurological dis-
eases management [3].
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Recently, increasing research investigated the feasibility
and benefits of DTs to remotely monitor people with
dementia.
The American Academy of Neurology has developed
a guidance for clinicians and practices to implement
telemedicine services amid the COVID-19 crisis, with
obvious limitations to some specific parts of the neuro-
logical examination (e.g., fundoscopy, reflexes, etc.)
which, nonetheless, may be not fundamental, particular-
ly in the follow-up interview of a patient already diag-
nosed with CI [4].
As postponing planned referrals will increase the future
workload and delay proper update in themanagement of people
with CI, a follow-up visit with telemedicine approach may pro-
vide timely referrals, thus avoiding delays or engulfment of the
waiting lists. Specifically, videoconferences and videomonitor-
ing have been shown to be as efficient as in-person visits in
evaluation of daily living activities and global cognition [5].
Also, the diagnostic process can be facilitated through tele-
medicine and DT. Indeed, although instrumental examinations
are paramount for the detection of physiopathological bio-
markers of disease (e.g., cerebrospinal fluid, amyloid PET), a
preliminary telemedicine consultation could be helpful in indi-
viduating the patients who actually need to be further tested.
Accurate neuropsychological evaluations are possible
through telemedicine. Although further studies are need-
ed to test the reliability of complex tasks requiring mo-
tor and visual abilities, there is growing scientific evi-
dence supporting the use of videoconferencing technol-
ogy in the remote administration of neuropsychological
tests, particularly those that rely on verbal responses [6].
There is preliminary evidence that smartphone-based as-
sessment of episodic memory [7], cognitive processing speed
[8], and visual attention [9] are reliable tools to evaluate cog-
nitive functions in preclinical populations and to monitor pro-
gression of cognitive decline in patients with CI.
Telemedicine and e-health services are also available
to support care for older adults and family caregivers.
Internet-based technology can support people at early
stages of CI through electronic reminders, daily activi-
ties, and cognitive stimulation games [10]. Even more
important, most of the new DTs are devoted to support
caregivers. Readily available web-based training and
psycho-educational programs [11] improve knowledge
and competence for caregiving, reducing caregiver psy-
chological burden [12]. Also, mobile text messaging,
video-recording, and chat forums can be useful for
meeting specific caregivers’ needs. Crucially, there is
an increasing request and high level of satisfaction for
technological support in assisting caregivers [13].
Thus, the activity of a memory clinic may partially contin-
ue during the current pandemic, albeit with some expedients.
The adoption of a virtual clinic is necessary for avoiding
traditional face-to-face visits for vulnerable patients, without
hampering the quality of neurological consultation. We rec-
ommend the use of electronic health record systems (that
could be easily implemented through online tools, such as
Google Forms) and e-mails for faster communication (e.g.,
report or visualization of diagnostic examinations and medical
prescriptions). Then, after the first contact with patients and
caregivers, we suggest tailoring the best tele-medical support.
Neuropsychologists should be trained also to familiarize with
video conference testing, and some tests should be readily
converted into a digital version.We believe that it is necessary
to make a preliminary selection of patients based on their
diagnostic/management process in order to avoid manage-
ment or diagnostic delays. Depending on patients and care-
giver willingness, a teleneurology consultation could be con-
ducted via video call to obtain more details on patient’s con-
dition, and this is strongly advised in case of new referrals.
The teleneurology may offer a cost-effective and
practical method for delivering interventions to dementia
patients and caregivers, especially through the COVID-
19 pandemic, favoring the adoption of new ways to
deliver medical care.
However, this modern approach could encounter several
limitations, due to the availability of appropriate conditions
to perform tele-consultations (e.g., quality of connection, pa-
tient’s ownership of webcam), knowledge and familiarity of
patients and caregivers with these modern technologies, and
ethical concerns which require caution and specific privacy
policy to protect sensitive data such as compliance to the na-
tional General Data Protection Regulation.
Independently from the current COVID 19 pandemic, the
application of technological devices in dementia care may
lead to several advantages such as improving access and qual-
ity of care, servicing patients coming from rural communities,
and supporting caregivers. The next step is to encourage a
widespread adoption of telemedicine services promoted by
healthcare boards directives.
Here we suggested different telemedicine and DT ap-
proaches that can be easily used to keep on providing accept-
able standards of care during this pandemic. Once the needs of
people with CI and their caregivers will be identified, and the
strategies for their assistance established, an appropriate techni-
cal support could ease the life of many people [13]. Follow-up
visits, cognitive and digital markers, and effective supporting
measurements can be very helpful at the present time.
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